Quidelortho Corp key statistics and ratios
In fiscal 2025, Quidelortho Corp had return on equity of -46.1% and a net margin of -41.5%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2020Jan 2021 | 2021Jan 2022 | 2022Jan 2023 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Net margin | 48.8% | 41.5% | 16.8% | −0.3% | −73.7% | −41.5% | −39.2% |
| Return on equity | 60.8% | 43.2% | 16.0% | −0.2% | −51.4% | −46.1% | −56.7% |
| Return on assets | — | 29.0% | 9.7% | −0.1% | −27.4% | −18.6% | −18.3% |
| Effective tax rate | 22.1% | 21.8% | 25.4% | — | — | — | — |
| R&D as % of revenue | 5.1% | 5.6% | 5.8% | 8.2% | 7.9% | 6.8% | 6.8% |
| SG&A as % of revenue | 10.9% | 14.1% | 19.0% | 25.5% | 27.6% | 27.3% | 28.8% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Net margin | −2.7% | −25.2% | −1.8% | −41.6% | −104.7% | −18.1% | −14.8% | −14.7% |
| R&D as % of revenue | 7.7% | 6.7% | 7.7% | 7.4% | 5.9% | 6.3% | 7.2% | 7.7% |
| SG&A as % of revenue | 25.6% | 26.5% | 27.0% | 29.0% | 26.7% | 26.9% | 32.2% | 30.1% |
Financial health
- Short-term assets cover short-term liabilities $1.4bn of assets due within a year against $993m of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.4bn short-term assets against $2.9bn of longer-dated liabilities.
- More cash than debt $123m of cash against $2.9bn of debt.
- Debt below 40% of shareholders' equity Debt is 163% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 0% to 163% over five years.
- A year's operating cash flow covers at least 20% of debt −$57m of operating cash flow against $2.9bn of debt.
- Operating profit covers interest at least five times over Operating income of −$825m against $203m of interest.
Moat
Weak moat
How hard Quidelortho's competitive advantage looks for rivals to wear away, judged from 5 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Net income has been a median -7.3% of total assets over 5 years.
- Durability 10 / 20
Operating margin has been a median -8.5%; its worst year was -63.8%.
- Cash conversion 6 / 20
Free cash flow was positive in 3 of 5 years, at a median 0.5% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Revvity statistics
- Insulet Corporation statistics
- Enovis Corp statistics
- Globus Medical Inc statistics
- Teleflex Inc statistics
Head to head: QDEL vs RVTYPODD vs QDELENOV vs QDELGMED vs QDEL
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies